Find News

Filter articles

Showing 21 to 30 of 3629 results

Australian court rejects Boehringer opposition bid against MSD unit’s anti-parasitic drug patent

Australia24-05-2022Sarah Speight

The Federal Court of Australia has refused an appeal request in a decade-long case brought by Boehringer Ingelheim Animal Health against MSD subsidiary, Intervet International.

OptraHealth sues Invitae over genetic testing chatbot

US24-05-2022Muireann Bolger

OptraHealth has filed a patent infringement lawsuit against Invitae that centres on the latter’s Gia chatbot that offers genetic testing and advice.

NIH COVID-19 deal broadens access for poorer nations

International19-05-2022Sarah Speight

The Medicines Patent Pool and World Health Organization’s COVID-19 Technology Access Pool have signed a deal aiming to open up new technologies to people living in poorer countries.

USPTO urges Vidal review of Arthrex petition

US19-05-2022Muireann Bolger

The US Patent and Trademark Office has argued against a bid by medical device maker Arthrex, which wants recognition that an ex-interim acting director lacked the power to refuse to review its petition.

Roche and Bluebird settle ‘Spark’ TM suit

US19-05-2022Alex Baldwin

Roche subsidiary Spark Therapeutics has settled a lawsuit with rival gene-therapy company Bluebird Bio, which it had accused of infringing its “Spark” trademarks when marketing treatment for sickle-cell disease.

Natera accuses CareDx of infringing DNA testing patents

US17-05-2022Muireann Bolger

Natera has accused rival medical company CareDx of infringing two patents covering its “cell-free” DNA testing technology, Prospera.

Emcure says court should dismiss COVID vaccine secrets suit

US17-05-2022Alex Baldwin

Indian pharmaceutical company Emcure has asked a Washington court to toss a lawsuit accusing the company of stealing trade secrets related to a COVID-19 vaccine.

Beckman Coulter loses late-stage bid to pause infringement proceedings

US17-05-2022Alex Baldwin

The US District Court for the District of Delaware has denied a motion from Beckman Coulter to stay an patent infringement lawsuit involving Sysmex Corporation until parallel proceedings at the US Court of Appeals for the Federal Circuit are concluded.

BMS says Hengrui’s Abraxane infringes

US13-05-2022Alex Baldwin

A subsidiary of Bristol-Myers Squibb has sued Chinese pharma company Jiangsu Hengrui Pharmaceuticals, alleging that the company’s planned generic of cancer medication Abraxane infringes a patent.

Novartis' Gilenya patent survives invalidity bid

US12-05-2022Alex Baldwin

Novartis has convinced a Delaware court that a patent for its flagship multiple sclerosis treatment Gilenya is directed at patent-eligible matter, dismissing a challenge from Handa Pharmaceuticals that the patent is directed at natural phenomena and invalid.

Showing 21 to 30 of 3629 results